TABLE 1:

Patient characteristics

ControlsCS−CS+
Number of subjects151413
Age (y)45 ± 1049 ± 1358 ± 16
Gender (M/F)1/143/113/10
Disease duration (y)11 ± 106 ± 7
Prednisone, daily oral dosage (mg)9.2 ± 2.8
Prednisone, lifetime oral dosage (g)4.4 ± 4.9
  • Note.—CS indicates corticosteroids.